Synthetic design of growth factor sequestering extracellular matrix mimetic hydrogel for promoting in vivo bone formation by Yan, HJ et al.
  
 




Hyaluronic acid hydrogel with growth factor sequestering capability for 
promoting in vivo bone regeneration 
 
Authors:  Hong Ji Yan1, Tommaso Casalini2, Gry Hulsart-Billström3, Shujiang Wang4, 
Oommen P. Oommen5, Matteo Salvalaglio6, Sune Larsson3, Jöns Hilborn4, and Oommen P. 
Varghese 4,* 
Affiliations: 
1Royal Institute of Technology, Stockholm, SE-106 91, Stockholm, Sweden. 
2Institute for Chemical and Bioengineering, Department of Chemistry and Applied Biosciences, 
ETH Zurich, Vladimir-Prelog-Weg 1, 8093 Zurich, Switzerland. 
3Department of Orthopedics, Uppsala University, Uppsala, Sweden. 
4 Institute of Polymer Chemistry, Department of Chemistry, Uppsala University, SE-751 21 
Uppsala, Sweden. 
5Bioengineering and Nanomedicine Lab, Faculty of Biomedical Sciences and Engineering & 
Biomeditech Institute, Tampere University of Technology, Tampere, Finland, 33720 
6Department of Chemical Engineering, University College London, London WC1E 7JE, UK 
• E-mail: Prof. Oommen P. Varghese oommen.varghese@kemi.uu.se 
 
One Sentence Summary: Tuning hyaluronic acid backbone protonation state in a 3D-hydrogel 
regulates BMP-2 release and osteogenic induction in vivo. 
Abstract  
Synthetic scaffolds that possess an intrinsic capability to store, protect and sequester sensitive 
growth factors is a primary requisite for developing successful tissue engineering strategies. 
Growth factors such as recombinant human bone morphogenetic protein-2 (rhBMP-2) are highly 
susceptible to premature degradation and to provide meaningful clinical outcome require high 
doses. Such high doses manifest undesired side effects. We have discovered a unique and 
straightforward strategy that stabilize and sequester rhBMP-2 by enhancing the molecular 
interactions with an extracellular matrix component, namely hyaluronic acid (HA). We found 
that by tuning the protonation and deprotonation states of carboxylic acid residues of HA in a 
covalently crosslinked hydrogel, resulted in a controlled release of active BMP-2.  At neutral pH, 
BMP-2 release is primarily governed by Fickian diffusion through the hydrogel, whereas at 
acidic pH both diffusion and electrostatic interactions between hyaluronic acid and BMP-2 
become important. The molecular interaction of BMP-2 with HA at different pH was also 
demonstrated using molecular dynamic simulations, which corroborates with the in vitro protein 
release profile. Our results were equivocally validated in an in vivo rat ectopic model with 
rhBMP-2 loaded hydrogels, which demonstrated superior bone formation with acidic hydrogel 
compared to the neutral counterpart. We believe this study provides new insight on growth factor 
stabilisation within scaffolds and highlights the therapeutic potential of engineered ECM 
mimetic matrices for the delivery of rhBMP-2 and may help to curtail the adverse side effects 
associated with the high dose of the growth factor currently in clinical practice. 
Introduction 
Strategies involving delivery of growth factors using scaffolds are widely explored for 
regenerative medicine applications (1). They are particularly important for treating large bone 
defects (critical size) that fail to heal by themselves. Large bone defects are commonly treated 
using autologous bone grafting where healthy bone tissue from patient is harvested and 
implanted at the defect site. However, lack of transplantable bone, donor site morbidity and lack 
of good quality bone tissue in elderly patients (2) results in suboptimal clinical outcome . Thus, 
regenerative medicine-based approaches are developed in order to accelerate bone healing. To 
differentiate bone-forming mesenchymal stem (progenitor) cells towards osteoblasts, specific 
growth factors are needed, where the most potent are the morphogenetic proteins (BMPs) namely 
BMP-2 and BMP-7 (3). Recombinant human (rh) version of both these proteins are approved for 
clinical use by FDA (US Food and Drug Administration) as well as EMA (European Medicines 
Agency), however, due to severe risks of side-effects, rhBMP-7 also called OP-1 (Osteogenic 
Protein-1) is withdrawn from the market whereas rhBMP-2 (InductOs®) is currently having 
limited sale in Europe. Recently, an extensive debate has taken place on the clinical use of 
rhBMP-2 since several complications are observed in patients, which include acute respiratory, 
neurological and inflammatory complications (4). This led the FDA to issue a public health 
notification of life-threatening complications (5). The primary cause of such severe 
complications is due to the supraphysiological dose of rhBMP-2 (1.5 mg mL-1) that is used 
clinically with a collagen sponge-based carrier. Such high doses are needed because collagen-
based scaffolds are not effective in stabilizing rhBMP-2 in vivo (6). It is interesting to note that 
at high doses, BMP-2 induces adipogenic differentiation of MSCs by activating PPAR-γ 
(peroxisome proliferator-activated receptors) pathway (7) and at the same time activates bone 
resorbing osteoclasts (8), resulting in poor quality bone.  
BMP-2 is an unstable protein that easily undergoes denaturation resulting in loss of 
function. We have recently confirmed that rhBMP-2 undergoes aggregation at physiological pH 
and adheres to hydrophobic surfaces such as cell culture plastics and Eppendorf tubes (9). 
Recently, this association of BMP-2 to hydrophobic surfaces has been utilized to develop 
nanocarriers for efficient delivery of the protein in vivo (10). In living systems, soluble forms of 
growth factors are stabilized by the biopolymers present in the ECM (extracellular matrix) that 
regulate dynamic stem cell niche (11). Thus several researchers, including our group, have 
attempted to develop ECM mimetic scaffolds to deliver functional BMP-2 in vivo (12, 13). 
Several strategies have been employed to increase the bioavailability and stability of this protein. 
These strategies include engineering recombinant protein with a specific ECM binding motif to 
control sequestration (14), immobilizing protein by covalent conjugation (15), electrostatic 
binding to modified surfaces (16), and incorporating specific BMP-2 binding peptides or 
glycosaminoglycans (GAGs) such as heparan sulfate into the scaffold (17). Although these 
strategies are promising, they are cumbersome entailing complex bioengineering steps that often 
result in the loss of function due to covalent/electrostatic immobilization. It is noteworthy that 
rhBMP-2 is stable and remains biologically active when constituted at acidic pH (~4.5) resulting 
in efficient ectopic bone formation (18). Scaffolds also play a crucial role in dictating the 
bioactivity of this growth factor. The BMP-2 complexed to different scaffolds may result in 
either stimulatory or inhibitory effects in bone formation. The stimulatory effect is attributed to 
the increase in BMP-2 half-life by minimizing interaction with BMP antagonist noggin (17), 
whereas the inhibitory effect is due to inefficient binding of BMP-2 to its cognate receptor (19). 
BMP-2 complexing biomolecules such as HA, chondroitin sulfate and heparin also have a unique 
biological function related to the coagulation and complement system of the blood that also 
affect the biological outcome (20). These results prompted us to design a BMP-2 sequestering 
3D scaffold without using any special complexing agents that could enhance the stability and 
bioavailability of BMP-2.  
In this article, we describe a novel strategy to engineer HA hydrogel having different 
carboxylic acid protonation states such that it differentially interact with rhBMP-2 and regulate 
controlled release kinetics of bioactive BMP-2. In order to gain insight on the influence of 
backbone protonation of HA to bind BMP-2 within the HA-gel, we performed a multiscale 
modeling approach combining fundamental mass balances with simulations at the molecular 
level. The results of the computational analysis as well as the in vitro release experiments were 
further corroborated by in vivo experiments in a rat ectopic model. In summary, we present a 
new insight in material design that is simple and translatable, which could pave the way to 
develop safe and cost-effective regenerative medicine strategies.  
Results  
Hydrogel preparation and characterization 
We fabricated two HA hydrogels having different pH, by modifying the synthetic procedure 
from our previously optimized hydrazone crosslinked hydrogel that was obtained by mixing 
carbohydrazide modified HA derivative with aldehyde modified HA derivative (13). The 
hydrazone crosslink exhibited excellent stability at physiological pH, which is attributed to the 
extensive delocalization of charges over the urea-type linkage. To prepare hydrogel components 
having acidic pH, we synthesized the HA derivatives as previously reported and performed 
dialysis under acidic pH (~3). However, to develop neutral gels, we neutralized the purified 
hydrogel components to pH 7.4 by using 0.1 M NaOH and subsequently dialysed them against 
water (see experimental section for details). Both HA hydrogels were prepared by mixing 1:1 
ratio (v:v) of the HA-aldehyde and HA-hydrazide components in phosphate buffer saline (PBS, 
pH 7.4). The final pH of the hydrogel was determined by measuring the pH of the gel 
components before mixing and was found to be ~4.5 for acidic hydrogel and ~7 for neutral gel. 
These HA hydrogels were subjected to rheological assessment before and after swelling in 
phosphate buffer. Time-sweep rheological evaluation was performed to determine the gel point 
of the two-hydrogel systems, i.e., pH 4.5 (acidic) and pH 7 (neutral) HA-hydrogels. These 
experiments indicated that the acidic hydrogel had a shorter gelation time (90 seconds) whereas 
the neutral hydrogel took 13 minutes to reach the gel point (Figure 1A, B). Gel characteristics 
after complete crosslinking (i.e., after 24 h of curing) reveals that the neutral hydrogel was more 
rigid (~300 Pa after swelling) than the acidic hydrogel (Figure 1C, D and Table 1). This was 
also reflected in the calculated average molecular weight between crosslinks (Mc) and the pore 
size (ξ), which shows that neutral hydrogel had lower Mc and smaller ξ (13). However, the 
acidic and neutral gels had similar swelling and hyaluronidase (HAse) mediated enzymatic 
degradation rate (Table 1).  
In vitro release of bioactive rhBMP-2 from acidic and neutral HA hydrogels 
Next, we evaluated the release of functional BMP-2 from our HA-gels. Even though it is 
generally accepted that association of BMP-2 with the scaffold and its controlled release is 
important, there exist some disagreements on the physiological dose that is needed to be released 
at different stages of bone formation. Some researchers suggest that initial burst release followed 
by sustained release is important (21) whereas other reports indicate that controlled release is the 
key for effective bone induction (6). Nevertheless, it is generally accepted that high burst release 
as observed from collagen sponge is not desirable (6, 22). To evaluate the differential binding 
and release properties of functional rhBMP-2 from the two hydrogel systems having different 
pH, we performed in vitro ALP assay in BMP-responsive mouse stromal cell line (W-20-17) 
from the released media obtained as a function of time. This indirect approach is superior to 
conventional approach as it estimates only the biologically functional BMP-2 released from the 
gels. These experiments revealed that the acidic hydrogels showed a linear increase of ALP 
activity from day 1 to day 28. However, rhBMP-2 released from the neutral hydrogels exhibited 
initial burst release with nearly 65% of active rhBMP-2 released by day 7 (Figure 2). 
To understand the differences in release rate of rhBMP-2 from the two types of HA 
hydrogels, we performed modeling experiments by employing the fundamental mass balances, 
i.e. Fick's second law of diffusion written in cylindrical coordinates and considering axial 
coordinate only (Equation 1): 
          (1) 
Cprotein is protein concentration in the HA hydrogel, D is the diffusion coefficient and z is 
HA vertical hydrogel axis.  
Since the experiment was performed in a trans-well setup, the protein could be released 
only through the bottom surface of the HA hydrogel; therefore, only the axial coordinate was 
considered in the equation. The diffusion coefficient was fitted in order to best reproduce the 
experimental data, assuming that after 28 days a complete release has been achieved. This 
resulted in D values of 2.19 × 10-7 cm2 s-1 and 4.11 × 10-7 cm2 s-1 for acidic and neutral 
hydrogels, respectively. Comparison between simulated and experimental results is shown in 
Figure 2. These results suggest that the protein release at physiological pH can be reasonably 
described as a Fickian behavior (where the molecular diffusion is the most important 
phenomenon). On the other hand, BMP-2 release at pH 4.5 exhibits a substantial deviation from 
Fickian behavior, indicating that molecular diffusion is not the only mechanism affecting release 
rate (Figure 2).  
We, therefore, proposed a new model to understand the protein release characteristics at 
acidic pH, assuming that the attainment of interactions between the protein and the matrix can 
influence BMP-2 diffusion within the hydrogel. In this framework, the protein can be bound to 
the polymer matrix or move freely in the water-filled pores, resulting in a release profile that 
involves both molecular diffusion and protein desorption from hydrogel chains. It is also 
assumed that before release onset, bound and free protein fractions are at equilibrium. A mass 
balance for unbound (Equation 2) and bound protein (Equation 3) is described as follows:   
    (2) 
      (3) 
kdes is desorption constant, Cprotein,b is adsorbed protein concentration, Cprotein,u is protein 
concentration in water filled pores, and Cprotein,eq is the protein concentration in the water-filled 
pores at equilibrium with the bound protein.  
Diffusion coefficient D, desorption constant kdes and protein concentration at equilibrium 
Cprotein,eq have been fitted against experimental data at pH 4.5 which resulted in D, kdes and 
Cprotein,eq values to be 1.2 × 10-6 cm2 s-1, 3.47 × 10-6 s-1 and 7.14 × 10-4 µmol cm-3 respectively. 
Comparison between experimental and calculated data is shown in Figure 2, which indicates that 
our proposed model is in a good agreement with the experimental protein release profile at acidic 
pH. The obtained interaction parameters with our protein release experiments are summarized in 
Table 2.  
Fitted parameters allowed qualitative estimation of the characteristic time scale for both 
desorption (τdes) and diffusion (τdiff) phenomena: 
          (4) 
          (5) 
The obtained values for τdes and τdiff are 2.88 × 105 s and 2.99 × 105 s respectively. The 
reliability of the calculated diffusion coefficients was determined by estimating the 
corresponding value in water solution. Since the experimental diffusivity of BMP-2 in aqueous 
environment is not reported so far, we employed the equation proposed by Hem et al. (23): 
          (6) 
Where T is the absolute temperature, η is water viscosity (equal to 0.682 cP, at 37 °C), M 
is protein molecular weight (equal to 28,000 g mol-1) and RG is the radius of gyration (set equal 
to 2.05 nm, computed from molecular dynamics simulations, vide infra). This allowed obtaining 
a diffusion coefficient value equal to 1.25 × 10-6 cm2 s-1. 
The development of interactions between the protein and the matrix was investigated 
using simulations at a molecular scale, according to the adopted multiscale modeling approach. 
To estimate the affinity between HA and rhBMP-2 at neutral and acidic pH condition, we 
performed molecular dynamics simulations. For this purpose, BMP-2 atomic coordinates were 
taken from crystallographic structure available in the literature (PDB code: 1REW (24)) and the 
protonation states as a function of pH were evaluated by means of H++ software (25). The 
system under investigation was modeled with the BMP-2 protein interacting with a model chain 
of HA composed of 6 monomers (i.e. 12 disaccharide units). Glucuronic acid moieties are 
assumed to be fully dissociated at both considered pH values, as the pKa value for HA is 
approximately 3 (26). 
The structures of BMP-2–HA complexes input guess geometries for simulations were 
obtained by means of molecular docking. As described in the literature, BMP-2 exhibits a ‘wrist-
knuckle’ 3D structure where the ‘wrist’ epitope of BMP-2 binds to the type I receptors (24, 27), 
while the ‘knuckle’ epitope binds to the type II receptors presented on the cell surface (28). Wrist 
and knuckle epitopes were considered as potential binding sites in the docking procedure, as well 
as the upper and lower portion of the protein. To simplify the nomenclature, the input 
arrangement obtained through docking, are arbitrarily named as wrist (Figure 3A), knuckle 
(Figure 3B), upper (Figure 3C) and lower (Figure 3D) geometries depending on the structure.  
For each input guess structure, 75 ns molecular dynamics simulation was performed at 
310 K and 1 atmosphere with explicit water molecules and ions to reproduce the physiological 
environment (PBS). The interaction energy between BMP-2 and HA model chain was computed 
using the last 25 ns utilizing Molecular Mechanics Poisson Boltzmann Surface Area (MMPBSA) 
approach. Results are summarized in Table 3, which includes interaction energy values ∆E along 
with electrostatic and Van der Waals contributions. 
The computed energies demonstrated that the electrostatic interactions between the solute 
and the matrix are more favorable at pH 4.5 than at pH 7 (except the lower complex). To explain 
the obtained results, we computed the electrostatic potential on protein surface using 
representative snapshots from simulations (Figure 4A and 4B). Blue colored areas represents 
positively charged regions, while the red ones indicate negatively charged regions; the 
electrostatic potential is expressed in the dimensionless unit kBeT-1, where kB is Boltzmann 
constant, e is electron charge, and T is the absolute temperature. The overall protein charge is 
equal to +4 and -8 at pH 4.5 and 7 respectively. On one hand, this implies the presence of large 
positively charged areas at pH 4.5 (Figure 4A) that could favor the binding of negatively 
charged HA (Figure 4C). On the other hand, the negative charge of BMP-2 at pH 7 can hinder 
the formation of stable complexes. Representative complex structures at pH 4.5 and pH 7 are 
shown in Figure 5 and Figure 6 respectively, along with electrostatic potential on protein 
surface.  
This analysis was complemented by computing hydrophobic patches located on protein 
surface by means of Spatial Aggregation Propensity (SAP) algorithm proposed by Chennamsetty 
et al. (29). As shown in Figure 7, red-colored areas represent the hydrophobic regions, whereas 
the blue regions indicate the hydrophilic domains. The neutralization process was qualitatively 
simulated by starting from the equilibrated complexes obtained at pH 4.5 followed by changing 
the protonation state of the protein to pH 7. Additional 75 ns molecular dynamics simulations 
were performed to obtain equilibrated structures and the last 25 ns of each trajectory were used 
for computing interaction energy using the MMPBSA approach, as summarized in Table 4. 
These experiments reveal that the obtained interaction energies are less favorable at 
neutral pH than the ones at pH 4.5, due to non-favorable electrostatic interactions. The lower 
complex is an exception since it involves a positively charged binding area even at pH 7. 
Interestingly, our simulation experiments also demonstrate that the change in protonation state 
upon neutralization results in a rearrangement of complex structures to minimize the unfavorable 
electrostatic interactions and enhance Van der Waals interactions. Such a complex stabilization 
effect due to Van der Waals interactions are not observed in neutral hydrogels.  
In vivo osteogenesis of HA hydrogels containing rhBMP-2 
To evaluate the osteogenic potential of the two rhBMP-2-loaded hydrogels, we performed in 
vivo subcutaneous implantation of the HA hydrogels with low doses of rhBMP-2 (4 µg rhBMP-2 
in 200 µl HA hydrogels which correspond to 20 µg/mL) in a rat model. In vivo bone induction in 
terms of bone volume was quantified in live animals using dynamic µCT employing temporal 
scans to follow the same animals. Interestingly, the acidic HA hydrogels displayed detectable 
bone formation already after two weeks, whereas the neutral HA hydrogels showed detectable 
bone formation only by week six (Figure 8A). In addition, the acidic HA hydrogels produced 
significantly much larger bone volume as compared to the neutral hydrogels with the same BMP-
2 concentrations. This was evident at all time points tested and after eight weeks bone volume 
were 62.69 ± 22.09 (mm3) and 12.44 ± 3.16 (mm3) in the acidic hydrogels and 12.44 ± 3.16 
(mm3) in the neutral hydrogels (Figure 8A).   
The rats were sacrificed at week 8 and the ectopic bone was harvested. Samples were scanned 
individually by µCT ex vivo. Both the representatives of 3D construction images of the samples 
(Figure 8B and 8C) and the statistical analysis revealed that bone volume was significantly 
larger for acidic hydrogel implants (65 mm3) as compared to that of the neutral hydrogel 
implants (18 mm3) (Figure 8D). These values corroborate with the bone volume determined 
using dynamic in vivo µCT mentioned above. The histological evaluation was carried out on the 
ectopic bone explants of the acidic and neutral hydrogels. Representatives of cross sections 
stained by H&E and Masson’s trichrome revealed that newly formed bone induced by acidic 
hydrogel with rhBMP-2 (Figure 9A, B, C, D) exhibited a matured bone tissue with abundant 
adipocytes ‘a’ as in a bone marrow and mineralized bone ‘b’ with abundant osteoblasts (Figure 
9. The neutral hydrogel carrying rhBMP-2 however, induced neo bone (Figure 9E, F, G, H) 
with less mineralized tissue. We also observed some remnant of hydrogels in these gels, 
indicated as ‘g’ (Figure 9). It is noteworthy that we did not observe any inflammatory cells 
(Figure 9) or fibrotic tissue in the neo bone induced by both hydrogels with rhBMP-2. 
 
Discussion  
Controlled delivery of growth factors as drugs for regenerative medicine applications primarily 
relies on the carrier that is used. These carriers have to be biocompatible and should increase the 
pharmacokinetic and pharmacodynamics characteristics of the drug molecule. One such growth 
factor is BMP-2 that has been clinically used for bone regeneration applications. There are 
several challenges to overcome to use BMP-2 as a safe therapeutic agent, such as, minimize 
required dosage, control drug release profile from the scaffold, improve the interaction of BMP-2 
with its cognate cell-surface receptors as well as increase its half-life. In this article, we present a 
novel strategy to stabilize rhBMP-2 and control its release to allow improved bone regeneration 
at lower doses.  
As a carrier of rhBMP-2 that differentially stabilizes protein, we envisioned to exploit the 
chemical behavior of the carboxylic acid functionality that is naturally present in HA, a natural 
component of ECM. Since the pKa of HA-carboxylate is around 3, designing injectable HA-
based hydrogel having ionizable carboxylic acid or its conjugate base (carboxylate) should 
render different stabilization of rhBMP-2. We have previously shown that rhBMP-2 remain 
stable at pH ~4.5 (also recommended in the product description) but undergo slow aggregation at 
physiological pH (9). Thus, hydrogels having differential protonation states (or inherent pH) 
should demonstrate differences in BMP-2 stability and bioactivity. To test this hypothesis, we 
selected our previously optimized HA-based hydrazone-crosslinking chemistry (13) but changed 
the material preparation protocol to develop the acidic and neutral hydrogel. Of note, this “click-
type” crosslinking chemistry is superior to the conventional hydrazone chemistry as it provides 
for significantly improved hydrolytic stability of the formed hydrazone linkages. The hydrogel 
thus obtained demonstrated similar physical properties as well as susceptibility to hyaluronidase-
mediated degradation. The rheological characterization of the acidic and neutral HA hydrogels 
showed similar gel characteristics as judged by modulus, mesh size and swelling ratio (Table 1), 
however, the gel point was reached at a shorter time point with the acidic gel as compared to that 
of the neutralized gel (Figure 1A, B). This is anticipated, as hydrazone formation is acid 
catalyzed, and at neutral pH such a reaction can be catalyzed by carboxylic acids residues present 
in HA backbone, as reported recently by our group (30). 
We further evaluated the in vitro release of biologically active rhBMP-2 from the two-
hydrogel systems using ALP assay in W20-17 cells. Interestingly, the 28 days release 
experiments showed two different release profiles of the bioactive rhBMP-2. To better 
understand the rhBMP-2 release characteristics, we subsequently modeled protein release by 
means of fundamental mass balances, i.e. by employing Fick’s second law of diffusion. 
Specifically, we estimated the diffusion coefficient of rhBMP-2 by fitting the experimental 
protein release data. As shown in Figure 2, this approach led to satisfactorily results for the 
release at neutral pH, while the agreement was quite poor at the acidic pH, confirming a 
substantial deviation from Fickian behavior. This can be attributed to the molecular interactions 
between the protein and the HA-chains within the hydrogel i.e., adsorption parameters that is not 
accounted for in the diffusion model. We therefore employed a diffusion/desorption model to 
describe the protein release, which is now due to the sum of two effects: diffusion of the free 
solute and irreversible desorption of the bound protein from HA chains. The desorption process 
is modeled as a first-order because of the low solute concentration. In this framework, the 
diffusion coefficient, the protein concentration (in the liquid-filled pores at equilibrium with the 
adsorbed one), and the desorption-constant are employed as fitting parameters. Such a fitting 
showed good agreement with the experimental release profile of rhBMP-2 at acidic pH. 
Assuming a uniform solute distribution, the initial protein concentration within the hydrogel is 
equal to 3.6 × 10-3 µmol cm-3. According to model best fitting, at pH 4.5 the protein 
concentration in the hydrogel bulk phase at equilibrium with the bound one is equal to 7.14 × 10-
4 µmol cm-3. This indicates that before release onset, about the 80% of the protein is bound to the 
matrix, and solute concentration in the water-filled pores is substantially reduced and close to an 
infinite dilution condition.   
The obtained diffusion coefficient is about one order of magnitude lower than the values 
computed considering only diffusion, at both pH 4.5 and pH 7. So far, there are no experimental 
data about BMP-2 diffusion coefficients in water or HA hydrogels. A representative reference 
value of BMP-2 diffusion in water at 37 °C at infinite dilution can be computed through 
available literature correlations, similar to the one proposed by Hem et al. (eq. 6) (23). Indeed, as 
mentioned, the low protein concentration inside the pores can be representative of an infinite 
dilution situation, which also implies a limited driving force for the diffusion out of the matrix. 
Moreover, the reduction of diffusion rate caused by HA is likely limited, since the mean mesh 
size is 12.4 nm for the acidic HA hydrogel, 11.6 nm for the neutral HA hydrogel being 
significantly larger than the 2.05 nm protein radius of gyration computed from the atomic 
coordinates taken from crystallographic structure.   
Model parameters allowed computing characteristic time scales for diffusion and 
desorption, equal to 2.88 × 105 s and 2.99 × 105 s, respectively. Such values are very close to 
each other, thus suggesting that desorption and diffusion have the same importance on the 
overall release behavior at pH 4.5, while at pH 7 the diffusion process dominates. 
To investigate the interactions between the protein and the matrix, we performed 
molecular dynamics simulations. For the sake of simplicity, the system is modeled as BMP-2 
interacting with a model chain of HA composed of six repeat units (that is, 12 sugar rings) in 
aqueous environment having physiological salt concentrations. Since experimental structures of 
complexes between BMP-2 protein and HA are not available in the literature, molecular docking 
procedure was necessary to obtain consistent guess geometries; this resulted in four different 
arrangements for each considered pH, which were used as input for molecular dynamics 
simulations. The affinity between the protein and the matrix was characterized by computing the 
interaction energies through MMPBSA approach. The obtained trend in energies demonstrates 
that the molecular interactions are more favorable at pH 4.5 due to the electrostatic contribution 
to the interaction energy (Table 3). Such interactions promotes binding at low pH while can 
hinder the formation of complexes in neutral conditions. This difference is related to the pH-
dependent state of protonation. On the HA the carboxylate anions remains largely undissociated 
also at pH 4.5, as it has pKa value of 3 (26). 
Interestingly, at neutral pH the protein has a total charge of -8 (according to H++ 
calculations), which changes to +4 when the pH drops to 4.5 thus promoting interactions with the 
negatively charged HA. The protein was further characterized by calculating the electrostatic 
potential on the surface (Figure 4A and 4B). These calculations showed that the net positive 
charge at low pH implies the presence of large regions with a positive electrostatic potential, 
which favors the binding through electrostatic interactions, as confirmed by MMPBSA 
calculations. As shown in Figure 5, in its binding pose HA preferably interacts with blue-colored 
regions, characterized by a positive electrostatic potential. On the other hand, because of the 
overall negative charge of the protein at pH 7, complex formation occurs through Van der Waals 
interactions involving hydrophobic patches on the protein, as shown in Figure 7 as confirmed by 
the relevant Van der Waals contribution according to MMPBSA calculations. In such a system, 
the HA chain is arranged to minimize the electrostatic repulsion between negatively charged 
moieties (Figure 6).  
We further investigated the molecular interactions between BMP-2 and the HA chain as a 
result of neutralization of acidic hydrogel. For this purpose, we selected the complex structures 
obtained at pH 4.5 and changed the protonation state of the protein to the corresponding one at 
pH 7. After additional 75 ns molecular dynamics simulations, interaction energies were 
computed by means of MMPBSA using the previous protocol. Notably, no unbinding events 
occurred, but complex geometries experienced a rearrangement aimed at minimizing 
electrostatic repulsion and enhancing Van der Waals interactions. The obtained interaction 
energies showed the same peculiarities at pH 7, namely a reduced affinity compared to pH 4.5 
due to an unfavorable electrostatic contribution.  
Despite such a marked alteration of its total charge, protein denaturation was not 
observed in the timespan of 50 ns for the isolated BMP-2 at pH 4.5. For the sake of 
completeness, it should be pointed out that in the employed protein input structure the 
coordinates of the first 11 amino acid residues are not available, since they are missing in the 
employed crystallographic structure. Each missing sequence contains four lysine and two 
arginine residues, which are expected to be protonated at both pH 4.5 and pH 7. This leads to a 
systematic underestimation of the overall protein charge, thus explaining the discrepancy 
between the BMP-2 charge at pH 7 and the experimental isoelectric point of BMP-2 (~8.2). 
Therefore, our results should be considered as lower level for binding affinities.  
The insights we obtained through the multiscale modeling, the system behavior can be 
rationalized as follows. At neutral pH, the affinity between the matrix and the protein is due only 
to Van der Waals interactions, which must counter-balance the electrostatic repulsion since both 
BMP-2 and HA exhibit an overall negative charge. Solute/matrix interactions are negligible; 
before release onset, all BMP-2 is available for release, which is due only to molecular diffusion. 
At acidic pH (i.e. 4.5), a high protein fraction is bound to the matrix because of electrostatic 
interactions. During the release, irreversible desorption from the HA occurs for two reasons. 
Firstly, BMP-2 in the water-filled pores diffuses out of the matrix and promotes desorption 
because of the deviation from adsorption equilibrium, and secondly neutralization weakens the 
mutual interactions and destabilizes the complexes. Therefore, at low pH BMP-2 release is due 
to the synergic effects of both molecular diffusion and desorption, which causes the deviation 
from the Fickian behavior.  
To investigate if our improved molecular understanding has any implications in reality, 
we examined the potential of our injectable hydrogels to induce bone formation in an animal 
model. Implantation of the acidic and neutral hydrogels ectopically in a rat model, with a 
significantly low dose of rhBMP-2 (4 µg/200 µL of hydrogel), indeed confirmed our findings 
with surprising efficacy. The acidic hydrogels gave nearly twice the amount of bone tissue 
volume as compared to the neutral hydrogels after eight weeks, as determined by µCT analysis 
(Figure 8). This clearly shows that the controlled release of the rhBMP-2 plays a major role in in 
vivo bone induction. Since, we evaluated a cell-free hydrogel system, the acidic hydrogel (that 
eventually will get neutralized) should be capable of recruiting endogenous stem cells and 
promote osteogenic differentiation. We have recently investigated this aspect and found that 
there is indeed a unique cell recruitment pattern (stem cells, M1 and M2 macrophages) in the 
different hydrogel systems, with and without rhBMP-2 (31).  
We further investigated the quality of neo bone by histochemical analysis. The H&E and 
Masson’s trichrome staining indicated ectopic bone formation induced by both acidic and neutral 
hydrogels. Direct comparison of the two-hydrogel system clearly demonstrated better quality of 
ectopic bone with acidic gel as compared to that of the neutral gel. The bone tissue obtained from 
the acidic gel indicated well-mineralized bony structure with adipocytes as in bone marrow 
(Figure 9A, B, C, D), unlike the neutral counterpart (Figure 9E, F, G, H). We anticipated the 
acidic hydrogels influenced the release of bioactive rhBMP-2, which facilitated the bone 
formation.    
 
Conclusions 
We present here a novel strategy to fabricate HA gels such that it differentially interacts 
with the BMP-2 and regulate its release at physiological pH. The HA derivative having the 
carboxylic acid groups enhanced binding to BMP-2 whereas the conjugate base (carboxylate) 
form of HA did not show such binding efficiency. The molecular interaction between BMP-2 
and HA was determined using molecular dynamic simulations, which demonstrated that at acidic 
pH molecular interactions were predominantly electrostatic, whereas at the neutral pH, Van der 
Waals interactions were dominant. Interestingly, these experiments indicated that reconstitution 
of the BMP-2 in the 3D scaffolds with intrinsic acidic or neutral properties modulate the stability 
and bioavailability of the growth factor over several weeks. The adsorption and desorption of the 
protein from HA having different binding mode were quantified by theoretical calculations 
which correlated well with the experimental release profile of bioactive BMP-2. The theoretical 
calculations imply that the BMP-2 release from the HA-gel, having neutral pH followed Fick’s II 
law of diffusion, whereas the protein release in acidic gel were controlled by both adsorption and 
diffusion phenomenon. These calculations also revealed that the neutralization of the acidic gels 
leads to complex rearrangement and improve BMP-2 binding to HA by Van der Waals 
interactions even though the electrostatic interactions were negated. Such interactions were not 
observed in the neutral gels.  In vivo bone induction experiments with these gels clearly 
demonstrated early mineralization (in just two weeks) in the acidic gel, unlike neutral gels that 
showed mineralization after six weeks. The total bone volume and bone quality also significantly 
improved in the acidic gel as compared to that of the neutral gel after eight weeks of 
experiments. Hence, by subjecting the HA gel and BMP-2 to lower pH promotes molecular 
interactions that retains and stabilizes the growth factor over several weeks in the gel although it 
is placed at physiological pH. In summary, this study offers a new insight on 3D matrix 
fabrication that significantly improves growth factor stability and bioactivity. Such a design 
increases the bioavailability of the sensitive growth factor that would subsequently reduce the 
drug dosage and mitigate the associated side effects.    
Materials and Methods 
Synthesis of hydrazide and aldehyde-modified HA-derivatives 
Synthesis of acidic HA-aldehyde and HA-hydrazide derivatives were performed following 
previously publication (32). The HA derivatives were purified by dialysis (Spectra Por-6, 
MWCO 3500) against dilute HCl (pH=3.5) containing 0.1 M NaCl (2×2L, 48 h), and then 
dialyzed against deionized water (2×2L, 24 h). The solution was lyophilized to obtain the desired 
acidic form of HA derivative having the carboxylic acid backbone.  
To prepare the neutral form of HA, the dialyzed product mentioned above was 
neutralized using 0.1 M NaOH and dialyzed against deionized water (2×2L, 24 h). 
Hydrogel preparation  
HA hydrogel was prepared following previous publication (32). Briefly, acidic and neutralized 
aldehyde and hydrazide derivatives of HA, mentioned above, were dissolved in 10 mM PBS (pH 
7.4) at a concentration of 16 mg/mL and sterilized by filtered through 0.45 µm syringe filter (Pall 
Corp., East Hills, NY). Thereafter, rhBMP-2 was pre-mixed with a HA-hydrazide solution to 
reach the concentration of 40 µg/mL. The two HA solutions were loaded into two 1 mL syringes 
with volume ratio of 1:1. The two syringes were connected at the tip with a connector, and the 
two solutions were mixed  ~20 times at room temperature to obtain hydrogel having final BMP-2 
concentration of 20 µg/mL. The gel was further kept for 3 h at room temperature before 
performing in vivo injection. 
BMP-2 release from hydrogels 
Both acidic and neutral HA hydrogels were prepared as described above. 20 µg BMP-2 was 
loaded to 200 µL gel. Three gels for each group were prepared individually. Hydrogels were 
placed into Corning® HTS Transwell®-24 well permeable supports HTS Transwell-24 units w/ 
0.4 µm pore polycarbonate membrane and immersed in 800  µL of PBS (total BMP-2 = 20 
µg/mL) and incubated at 37 °C. To determine the BMP-2 release from the gels 20 µL of samples 
were harvested at different time points (day 1, 3, 5, 7, 14, 21, 28).  Of the harvested samples, 5 
µL of the release medium was added to each well to perform the ALP assay. As a control, 20 
µg/mL BMP-2 was suspended in PBS and experiments were repeated in the same way as the 
BMP-2 release experiment, mentioned above, i.e., 20 µL samples were harvested for each time 
point to perform the ALP assay (corresponding to 100 ng BMP-2, if 100% released). The 
percentage of BMP-2 released at each time point is calculated with respect to the 100% released 
values obtained from the control experiments.  
Cell culture 
W-20-17 were maintained in DMEM containing 10% heat inactivated FBS and 1% antibiotics in 
humidified condition, 37 °C and 5% CO2. The medium was changed every second day. 
ALP activity assay and LDH assay 
For ALP activity and LDH activity study W-20-17 were seeded in 96 well plates with a density 
of 3 000 cells per well. After incubation for 24 h, cell culture medium was replaced by fresh 
medium containing 5 µL of the harvested samples in 100 µL of DMEM. For each time point, 5 
µL of the samples harvested from the control group without hydrogel was also evaluated. The 
levels of ALP in different cells were evaluated using our previously reported procedure (9). 
The cell lysate prepared for ALP assay was also used to determine cell number using 
LDH assay. Briefly, 50 µL LDH substrate (CytoTox 96®Non+radio cytotoxicity, Promega) was 
added into 20 µL of the remaining lysate and incubated for 20 minutes and the absorbance was 
measured at 490 nm. The final ALP levels were normalized to the observed LDH level.  
Molecular dynamics simulations 
Structural models 
The atomic coordinates of BMP-2 at pH 7 were obtained from the crystallographic structure 
(PDB code: 1REW) of a protein complex with its IA receptor (24); the protonation state at pH 
4.5 was evaluated by means of the H++ software (25). Partial atomic charges and force field 
parameters for BMP-2 were derived from Amberff03 force field (33). 
The atomic coordinates of HA were obtained through the crystallographic structure (PDB code: 
2BVK) (34) and replicated in order to build a hexamer, the model chain used to investigate the 
formation of BMP-2/HA complexes (35). All glucuronic acid units are assumed to be ionized; 
since the pKa value for HA is equal to 3 (26) at pH 4.5 the ratio between dissociated and 
undissociated glucuronic acid units is about 32. Thus, in this framework, the presence of non-
ionized carboxyl moieties can be reasonably neglected. 
GLYCAM06 (revision h) (36) force field was chosen to model HA oligomers. 
Molecular docking 
Molecular docking was employed to generate sets of plausible initial geometries for BMP-2/HA 
complexes at both pH 4.5 and pH 7 since, to the best of our knowledge, there are not 
crystallographic structures available in literature.  
First of all, relaxed structures of both protein and model chain were obtained through a 50 ns 
molecular dynamics simulation in explicit water at 300 K and 1 bar, using the simulation 
protocol explained below (vide infra). Molecular docking was performed by means of AutoDock 
Vina software (37), which allowed obtaining four input structures. For the sake of completeness, 
it should be pointed out that BMP-2 protein is a homodimer, with a disulfide bond between two 
cysteine units that connects the monomers.  
All animal experiments were performed in strict accordance to guidelines by FELASA 
and approved by Uppsala (Sweden) local committee for animal research ethics (C317/10).  Male 
Sprague Dawley rats weighing approximately 400g (n=4) (Scanbur AB, Sollentuna, Sweden) 
were allowed to acclimatize for one week prior to surgery.  Prior to surgery the rats were 
weighed and anaesthetized in an induction chamber with 5% isoflurane (Baxter, Sweden), 0.3 
L/min oxygen and 0.7 L/min nitrous oxide. The rats were transferred to an anaesthesia mask and 
the anaesthesia was reduced to 1–2.5% isoflurane, 1 L/min oxygen and 0.8 L/min nitrous oxide 
and placed on a heated pad during surgery. Each rat was shaved and then washed three times 
with chlorhexidine (Fresenius Kabi, Uppsala, Sweden). The rat received subcutaneous injection 
with 4 µg of rhBMP-2 in 200 µL of acidic or neutral HA hydrogels. Each rat received a total of 8 
implants, randomly assigned. Animals were subcutaneously administered buprenorfin 
(Temgesic, Schering-Plough, 0.05 mg/kg) during surgery for postoperative pain mitigation, 
which was continuously administrated for 3 days.  
µ-CT assessment  
To quantify the mineralization density of ectopic bone induced by BMP-2 delivered 
through the acidic and neutral hydrogels, in vivo dynamic scanning at week 1, 2, 4, 6, 8 and ex 
vivo scanning was performed on the harvested bone samples. SkyScan 1176 (Bruker, Kontich, 
Belgium) with X-ray source of 90 kV/150 µ and resolution of 36 µm were used for in vivo 
scanning and 45 kV/552 µA with resolution of 18 µm was used for ex vivo µCT assessment. The 
projections were reconstructed to cross-sections using NRecon (Bruker, Kontich, Belgium) with 
correction for misalignment, ring artifacts and beam hardening. The total bone tissue volume of 
the ectopic bone was determined using CTAn software (Bruker, Kontich, Belgium) applying 
global threshold. The 3D-reconstructions of samples were achieved by using 3D-DOCTOR 4.0, 
Able Software.  
Histological evaluation 
The ex vivo bone samples were fixed by formalin and decalcified by immersing in an 
electrophoresis system (Tissue-Tek Miles scientific, Histolab, Göteborg, Sweden) containing 
Osteosoft® decalcifying solution (Merck, Darmstadt, Germany) at room temperature overnight. 
Bone samples were embedded in paraffin and cut into 5 µm sections. Bone slides were 
deparaffinized, hydrated and then stained by hematoxylin/eosin (H&E) and Masson's trichrome. 
The sections were dehydrated and mounted with cover slides, scanned by automated image 
scanner (Aperio scanscope AT) and analyzed by Aperio ImageScope Software.  
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Fig. 1. Rheological evaluation of the acidic and neutral HA hydrogels. Insert (A, B) represents 
gelling kinetics whereas insert (C, D) represents mechanical properties of acidic and 


























Fig. 2. Experimental release of bioactive BMP-2 is indicated by marked scatter plot from acidic 
(blue) and neutral (red) gels. Continuous line corresponds to the theoretical release 
according to the Fick’s II law of diffusion, whereas the dotted lines represent the 
modified Fick’s model. In vitro release of bioactive BMP-2 was determined from the 
ALP activity assay in response to released rhBMP-2 from the acidic and neutral HA 
hydrogels for up to 28 days in W-20-17 cells. Data are shown as an average of triplicate 
wells from three individual experiments.   
 
Fig. 3. Examples of input HA–BMP-2 complex structures: (A) wrist, (B) knuckle, (C) upper and 
(D) lower geometries. 
 
Fig. 4. Electrostatic potential maps of BMP-2 at (A) pH 4.5, (B) at pH 7 and that of (C) HA at 
pH 7. Electrostatic potential ψ is expressed in kBTe-1 unit.   
 
Fig. 5. Representative HA–BMP-2 complex structures along with electrostatic potential maps 
relative to BMP-2 at pH 4.5: (A) wrist, (B) knuckle (C) lower and (D) upper. 
Electrostatic potential ψ is expressed in kBTe-1 unit. 
  
Fig. 6. Representative HA–BMP-2 complex structures along with electrostatic potential maps 
relative to BMP-2 at pH 7: (A) wrist, (B) knuckle (C) lower and (D) upper. Electrostatic 
potential ψ is expressed in kBTe-1 unit.   
 
Fig. 7. Hydrophobic interactions in HA–BMP-2 complexes in the (A) knuckle and (B) wrist 
structures along with hydrophobic patches relative to BMP-2 (after neutralization) at pH 
7.    
 
Fig. 8. Ectopic bone volume (BV) was quantitatively evaluated by micro CT (µCT) after 
implantation of acidic and neutral hydrogels in a rat model. (A) The dynamic µCT 
analysis in live animal at different time points indicating differences in BV observed in 
the acidic and neutral hydrogels (week 2 to week 8). (B) Ex vivo quantitative µCT 
analysis of ectopic bone tissues harvested at week 8. (C, D) Representatives of 3D 
reconstruction of images obtained from µCT after 8 weeks in acidic and neutral 









































Fig. 9. Histological evaluation of de novo bone induced by subcutaneous injection of rhBMP-2 
loaded acidic hydrogels (A, B, C, D) and neutral hydrogels (E, F, G, H) that were 
harvested after eight weeks of implantation. Hematoxylin/eosin (H&E) (A, B, E, F) and 
Masson's trichrome (C, D, G, H) staining were evaluated on paraffin-embedded cross 
sections. The abbreviations ‘a’ indicate adipocytes; ‘b’ indicates matured bone; and ‘g’ 
indicates remnant hydrogels. 
 
 
Table 1. Physical properties of acidic and neutral HA hydrogels before and after swelling 
 Before swelling After swelling 
sw% HAse* (h) 
G’ (Pa) G’’ (Pa) ξ (nm) Mc (kg/mol) G’ (Pa) G’’ (Pa) 
pH 4.5 2150±94 13.4±0.5 12.4 18.0 1574±105 14.0±1.1 24.8±3.4 20 
pH 7  2657±60 14.6±1.7 11.6 14.6 1867±28 12.1±0.6 28.1±3.0 25 
 
Table 2. Fitting parameters for diffusion and diffusion/desorption models 
 pH 7 pH 4.5 (diffusion model) pH 4.5 (diffusion/desorption model) 
D [cm2 s-1] 4.11 · 10-7 2.19 · 10-7 1.2 · 10-6 
kdes [s-1]  - - 3.47· 10-6 
Cb [µmol cm-3] 0 0 0 
Cprotein,eq [µmol cm-3]  - - 7.14· 10-4 
 
Table 3. Interaction energies for each HA–BMP-2 complex at pH 4.5 and pH 7, along with 
specific electrostatic and Van der Waals contributions. Values are expressed as average ± 
standard error 
 ΔE (kcal mol-1) Wrist Knuckle Lower Upper 
pH 4.5 Electrostatic -399.85 ± 4.65  -588.48 ± 1.90  -1009.29 ± 3.85  -703.30 ± 1.80  
Van der Waals -33.07 ± 0.51  -53.46 ± 0.23  -42.24 ± 0.41  -79.94 ± 0.29  
Total -16.25 ± 0.49  -33.50 ± 0.40  -33.68 ± 0.46  -39.66 ± 0.47  
 pH 7 
    
 
Electrostatic 664.55 ± 3.12  361.26 ± 4.12  -86.95 ± 3.60  708.41 ± 3.56  
Van der Waals -48.82 ± 0.69  -65.26 ± 0.61  -74.88 ± 0.68  -98.07 ± 0.71  
Total -12.43 ± 0.79  -26.67 ± 0.60  -47.91 ± 0.89  -9.61 ± 0.93  
 
Table 4. Interaction energies for each complex after neutralization, along with specific 
electrostatic and Van der Waals contributions. Values are expressed as the average ± standard 
error 
 
ΔE (kcal mol-1) Wrist Knuckle Lower Upper 
Electrostatic 453.59 ± 3.07  383.27 ± 1.60  -222.54 ± 5.08  425.02 ± 2.75 
Van der Waals -42.20 ± 0.55  -59.39 ± 0.31  -79.52 ± 0.51  -75.38 ± 0.24  
Total -11.12 ± 1.18  -1.39 ± 0.73  -46.95 ± 0.96  -25.36 ± 0.64  
